| Q48245285 | Activation of mGluR5 Attenuates Microglial Activation and Neuronal Apoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats |
| Q36661183 | Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury |
| Q36352348 | Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors |
| Q91807444 | Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives |
| Q39972669 | Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons |
| Q51013962 | Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease. |
| Q36551432 | Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture |
| Q28385047 | Metabotropic glutamate receptor-mediated signaling in neuroglia |
| Q37358665 | Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders |
| Q39445567 | Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury |
| Q58161307 | Progress in the Development of Platelet-Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases |
| Q36154940 | Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells |